Introduction
Recent advances in clinical laboratory techniques have opened new horizons for a better understanding of the role of platelets in thrombosis, immunity, inflammation and angiogenesis 1 . Platelets play a pivotal role in the development of atherosclerotic lesions, plaque destabilization, and atherothrombosis 2 .
Assessment of platelet function with mean platelet volume (MPV) level gained popularity in recent years. The MPV is a marker of platelet size and activation. It is more reliable measurement of platelet function than the platelet count alone. Increased MPV reflects active and large platelets. Elevated levels of MPV have been demonstrated to be an independent predictor for ischemic vascular events, recurrent MI or death from coronary artery disease 3,4,5 .
Coronary artery bypass graft (CABG) is the definitive surgical treatment of the coronary artery disease. In recent years, Overall mortality rate of coronary artery surgery is low, at around 2%-3%, although this benefit is offset by a complication rate 6 of 20%-30%.
There are limited data emphasizing the association of platelet activation with adverse outcomes following CABG 7 . Preoperative elevated MPV level was a strong independent predictor of combined adverse events, postoperative MI and major adverse cardiac events (MACE) 8 . Estimation of MPV is an easy and cost effective test. Therefore, within the single center registry of patients undergoing CABG surgery MPV was detected for prediction of outcome.
Materials and methods
An observational prospective study was carried out in the Department of Cardiovascular Surgery, National Institute of Cardiovascular Diseases (NICVD), Dhaka during the period from July 2012 to June 2014. Purposive convenient sampling technique was employed and inclusion criteria was patient undergoing conventional CABG surgery during the specified period. Exclusion criteria included (1) emergent surgery, (2) redo CABG, (3) off-pump CABG, (4) myocardial infarction within a week, (5) preoperative severe anemia (hemoglobin level <10 g/dl and/or hematocrit level <30%), (6) Patients with poor LV function (LVEF<30%) and (7) patients with stroke.
The patients were divided into two groups according to normal and elevated MPV at 10.60 femtolitre (fL) cut off level. Baseline clinical details and preoperative mean platelet volume were obtained prospectively in 81 consecutive patients. Blood samples were analyzed by automated hematology analysis system "SYSMEX Analyzer", Model-XT1800i. All patients' samples were processed within 2 hours after venipuncture to avoid bias due to excessive platelet swelling 9 .
Conventional CABG surgery was performed using standard procedures. Standard moderate hypothermic (30º-32ºC) cardiopulmonary bypass (CPB) used. Postoperative ACT was recorded after neutralization with Protamine and kept between 80-120 sec 10 . In all cases hemodynamic optimization was attempted by volume management, pacing support, catecholamines and other drugs administration when necessary. Postoperative mortality and major adverse events were recorded in the early postoperative period. Postoperative outcome variables were (1) Postoperative MI, (2) arrhythmia, (3) bleeding and (4) Death.
Results
Baseline characteristics were recorded in Table- I. Mean age of the studied patients were 53.22±7.88. Among them 70 were male and 11 were female. According toNew York Heart Association (NYHA) functional class 39(48.1%) were found class II and 42(51.9%) were class III. Maximum patients 69(85.2%) of this study had triple vessel disease and maximum patients 69(85.2%) were treated with 3 bypass grafts. Receiver operating characteristic curve (Fig-1) In logistic regression analysis( A total 34 patients who had MPV<10.60 fL were included in group A and a total of 47 patients who had MPV≥10.6 fL were included in group B. The mean age of the studied patients were 53.22±7.88 years ranging from 32 to 70 years. It was found that middle aged people were most commonly underwent CABG surgery in this study. Similar result was reported by Slavka et al 12 mentioned that after age of 50 years patients are most commonly suffered from ischemic heart disease.
During the follow-up after CABG operation, combined adverse events occurred in 27 patients (33.3%). This is an acceptable range of adverse events as it is estimated combined. Mortality rate was found3.7%. Statistically significant association of adverse events were found between group A and group B in the study population (p=0.011). Univariate analysis showed statistically significant difference of left ventricular ejection fraction (LVEF), Mean platelet volume (MPV) and total cardio pulmonary bypass time (CPB) with post CABG adverse events (p=0.037, p=0.011, p=0.035 respectively). Unal et al has shown statistically significant difference of MPV and total CPB time but no difference with LVEF 8 .
Preoperative MPV level over 10.60 fL was associated and a strong independent predictor only with combined adverse events, postoperative MI and MACE. These outcomes of the study population were mainly composed of events that may be associated with thrombosis such as postoperative MI, reoperation, early repeat revascularization and mortality. 
Conclusion
Preoperative elevated MPV level was found a strong independent predictor only with combined adverse events. Mean platelet volume is an important, simple, readily available, and cost effective tool. MPV is obtained by routine investigation Complete Blood Count (CBC). CBC is done to every patient as a part of preoperative preparation and can be useful in predicting the postoperative adverse events in patients undergoing CABG surgery by MPV. So that early precaution can be taken for prevention of those adverse events and appropriate management can be arranged. Since the cause-and-effect relationship of thesemeasures and the outcome might be variable and we thought that this might be a subject of a different study. Further large scale comparative studies should be carried out in future for prediction analysis of MPV between conventional and off pump CABG (OPCABG) surgery.
